BMP/Coco antagonism as a deterministic factor of metastasis dormancy in lung

5Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A recent Cell publication demonstrates that the secreted antagonist of transforming growth factor-beta ligands, Coco, can re-activate previously dormant metastatic breast cancer cells specifically in the lung by inhibiting bone morphogenetic protein (BMP) signaling. The authors provided evidence for a connection between Coco/BMP signaling and molecular and cellular traits of cancer stem cells. Their findings represent a significant advance in our understanding of metastatic dormancy, an extremely important clinical issue that remains understudied. Equally as important, this study also opens interesting avenues for future research. © 2013 BioMed Central Ltd.

Cite

CITATION STYLE

APA

Martinez, J., & Zhang, X. H. F. (2013). BMP/Coco antagonism as a deterministic factor of metastasis dormancy in lung. Breast Cancer Research, 15(1). https://doi.org/10.1186/bcr3350

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free